Gainers
- Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares surged 159.9% to $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain. Concurrently, Avenue Therapeutics announced that it would effect a 1-for-15 reverse stock split.
- PaxMedica, Inc. (NASDAQ:PXMD) jumped 53.5% to $3.33 as the company issued a corporate update after IPO. The company named Stephen D. Sheldon as CFO.
- Scienjoy Holding Corporation (NASDAQ:SJ) surged 33.4% to $2.2281 after declining 44% on Monday.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 28% to $6.54. InMed recently reported a FY22 net loss of $33.17 per share.
- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) jumped 24% to $1.2001. Bellerophon announced FDA acceptance of change to ongoing Phase 3 REBUILD study of INOpulse for the treatment of fibrotic interstitial lung disease.
- FingerMotion, Inc. (NASDAQ:FNGR) gained 23% to $0.9999 after rising around 20% on Monday.
- Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 21.6% to $2.48 after gaining over 11% on Monday.
- Grove Collaborative Holdings, Inc. (NYSE:GROV) shares climbed 21.3% to $3.5901. Grove Collaborative continued retail expansion with entry into thousands of more stores.
- Unico American Corporation (NASDAQ:UNAM) gained 20.8% to $1.5099.
- 9 Meters Biopharma, Inc. (NASDAQ:NMTR) rose 20.3% to $0.2490 after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
- Milestone Scientific Inc. (NASDAQ:MLSS) gained 20% to $0.8193.
- Avalon GloboCare Corp. (NASDAQ:AVCO) jumped 19.8% to $0.5271.
- Pyxis Oncology, Inc. (NASDAQ:PYXS) gained 19.8% to $2.30.
- Biocept, Inc. (NASDAQ:BIOC) gained 17.1% to $0.9368.
- Equillium, Inc. (NASDAQ:EQ) jumped 15.5% to $2.23. Equillium announced interim results from the Type B portion of the EQUALISE study evaluating itolizumab in patients with lupus nephritis (LN).
- Foghorn Therapeutics Inc. (NASDAQ:FHTX) rose 14.1% to $8.67.
- The Beauty Health Company (NASDAQ:SKIN) gained 12.6% to $11.71 after the company announced a $200 million buyback.
- Stryve Foods, Inc. (NASDAQ:SNAX) jumped 12% to $0.45.
- Skillz Inc. (NYSE:SKLZ) jumped 11.9% to $1.0750.
- Verve Therapeutics, Inc. (NASDAQ:VERV) gained 11.5% to $34.73.
- BitNile Holdings, Inc. (NYSE:NILE) rose 10.6% to $0.2047.
- CVR Energy, Inc. (NYSE:CVI) gained 8.2% to $27.65.
- BIT Mining Limited (NYSE:BTCM) rose 7.7% to $0.28 after declining around 9% on Monday.
- Novavax, Inc. (NASDAQ:NVAX) gained 7.5% to $20.28. Novavax announced an initial one million doses of Nuvaxovid are available for use in the UK.
